Summary: UltraSight and Mayo Clinic are developing AI algorithms for cardiac ultrasound to improve diagnoses and treatment using Mayo Clinic’s knowledge and data.

Key Takeaways:

  1. UltraSight and Mayo Clinic are developing AI algorithms for cardiac ultrasound to improve diagnoses and treatment decisions.
  2. Cardiovascular disease affects 130 million people globally, with over 75% prevalence in individuals over 60, highlighting the need for early detection and consistent care.
  3. The collaboration aims to democratize access to cardiac care knowledge, addressing the shortage of specialists and enabling more caregivers to use and understand ultrasound data.


UltraSight is collaborating with Mayo Clinic to enhance cardiac care using AI in point-of-care ultrasound. They will jointly develop algorithms to analyze and interpret cardiac ultrasound images. This collaboration aims to help healthcare providers make more informed diagnoses and treatment decisions using point-of-care ultrasound, or PoCUS, devices. By accessing Mayo Clinic’s team of researchers, clinicians, and data, UltraSight will enhance and scale its cardiac solutions.

Cardiovascular disease affects approximately 130 million people globally, increasing the demand for timely cardiac diagnosis and consistent care.

According to Paul Friedman, MD, chair of the department of cardiovascular medicine at Mayo Clinic, the prevalence of cardiovascular disease is over 75% in individuals over 60. Early detection can prevent the progression of heart disease or stroke. AI in point-of-care ultrasound can guide users in image acquisition and support image interpretation, making it scalable for early diagnosis and periodic cardiac monitoring.

John Halamka, MD, president of Mayo Clinic Platform, notes that training programs will not graduate enough specialists to meet the demands of an aging population. Embracing AI can democratize access to knowledge. Mayo Clinic and UltraSight aim to enable a wider spectrum of caregivers to obtain and understand cardiac ultrasound data, serving more patients globally.

Mayo Clinic is now an investor in UltraSight and has a financial interest in the technology referenced in this press release. Any revenue Mayo Clinic receives will support its not-for-profit mission in patient care, education, and research.